SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-290130
Filing Date
2019-11-12
Accepted
2019-11-12 17:20:56
Documents
4
Period of Report
2019-11-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d824234d8k.htm 8-K 22450
2 EX-1.1 d824234dex11.htm EX-1.1 215491
3 EX-5.1 d824234dex51.htm EX-5.1 9986
4 GRAPHIC g824234g82p57.jpg GRAPHIC 1915
  Complete submission text file 0001193125-19-290130.txt   251795
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36352 | Film No.: 191210851
SIC: 2834 Pharmaceutical Preparations